Teva Pharmaceutical Industries TEVA
NYSE TEVA
$43.14 +0.53 (+1.24%)
As of: Nov 9, 2026 · 10:52 AM EST

Teva Pharmaceutical Industries (TEVA) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Return on Invested Capital [ROIC] of 5.85% for Q3 2026, up 0.27 percentage points from 5.58% a year earlier but down 0.55 percentage points from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Teva Pharmaceutical Industries posted Return on Invested Capital [ROIC] of 9.01%, up 10.19 percentage points from FY2024.

  • Return on Invested Capital [ROIC] has a five-year change of +17.71 percentage points (FY2020 to FY2025).
  • By year, Return on Invested Capital [ROIC] came in at -1.19% in FY2024 (-2.67 pp), 1.48% in FY2023 (+6.94 pp), -5.46% in FY2022 (-8.73 pp) and 3.27% in FY2021 (+11.98 pp).
  • Five-year quarterly Return on Invested Capital [ROIC] spans a low of -5.78% in Q4 2022 and a high of 9.23% in Q1 2026.
  • Year over year, Return on Invested Capital [ROIC] has now increased in each of the last seven quarters, with an average year-over-year change of +2.84 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Invested Capital [ROIC] in five years was Q4 2021 (a gain of 12.74 percentage points); the low point was Q4 2022 (a drop of 9.13 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at 6.40% (Q2 2026), 9.23% (Q1 2026) and 8.84% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,249.15 Bn 1,222.76 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 672.28 Bn 592.14 Bn 17.30 Bn 17.57%
3 AbbVie 515.12 Bn 483.13 Bn 13.12 Bn 24.28%
4 Merck 364.35 Bn 327.29 Bn 13.19 Bn 2.88%
5 Novartis Ag 315.18 Bn 288.42 Bn - -
6 Astrazeneca 292.81 Bn 266.70 Bn 13.26 Bn 24.11%
7 Amgen 249.17 Bn 200.82 Bn 7.58 Bn 15.60%
8 Gilead Sciences 210.23 Bn 185.34 Bn 6.73 Bn -6.11%
9 Pfizer 165.64 Bn 113.00 Bn 12.56 Bn 12.34%
10 Teva Pharmaceutical Industries 50.27 Bn 35.23 Bn 2.44 Bn 5.85%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.85%
Jun 30, 2026 6.40%
Mar 31, 2026 9.23%
Dec 31, 2025 8.84%
Sep 30, 2025 5.58%
Jun 30, 2025 3.81%
Mar 31, 2025 1.88%
Dec 31, 2024 -1.25%
Sep 30, 2024 1.91%
Jun 30, 2024 3.35%
Mar 31, 2024 0.81%
Dec 31, 2023 1.56%
Sep 30, 2023 -4.54%
Jun 30, 2023 -4.12%
Mar 31, 2023 -3.71%
Dec 31, 2022 -5.78%
Sep 30, 2022 -2.34%
Jun 30, 2022 -1.70%
Mar 31, 2022 1.69%
Dec 31, 2021 3.35%
API Access

Teva Pharmaceutical Industries Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEY